Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Aug 19, 2011

Premium

The Swiss Institute of Bioinformatics has appointed David de Graaf and Alexey Nesvizhskii to serve on its scientific advisory board.

De Graaf is CEO of Selventa. Prior to that he was vice president of biotherapeutics and integrative biology at Boehringer-Ingelheim. He has also held positions at Pfizer, AstraZeneca, and the Whitehead Institute's Center for Genome Research.

Nesvizhskii is an assistant professor at the University of Michigan, Ann Arbor, where he specializes in quantitative proteomics, with a focus on developing computational methods for processing and extracting biological information from complex proteomic datasets. His lab develops computational tools and statistical methods for mass spectrometry-based peptide and protein identification and quantification; works on establishing guidelines and standards for proteomic data analysis and publication; and creates public databases and proteomic data repositories.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.